By building a portfolio of dividend paying stocks, you have potential to outperform while creating a supplemental income over ...

Key Takeaways JNJ will buy Intra-Cellular Therapies, producer of a drug for bipolar disorder, for $14.6 billion. Eli Lilly ...

U.S. equities were higher at midday Friday as positive reports on inflation raised investor optimism for more Federal Reserve rate cuts ahead.

Over the last 3 months, EPS estimates have seen 2 upward revisions and 12 downward. Revenue estimates have seen 3 upward revisions and 7 downward. Since the start of the year, 3M shares have risen 8.6 ...

Our reviewers — who are full-time investing writers and editors on NerdWallet’s content team — spend months researching brokerage accounts, extensively testing each broker's stock trading ...

Bank OZK (the "Bank") (Nasdaq: OZK) today announced that net income available to common stockholders for the fourth quarter of 2024 was $178.1 million ...

YARDLEY, Pa., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced ...

Rare Disease Segment performed in line with expectations, with Purified Cortrophin Gel net revenues of $197.8 million to $198 ...